{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:03:15Z","timestamp":1740106995061,"version":"3.37.3"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T00:00:00Z","timestamp":1660348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T00:00:00Z","timestamp":1660348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s00520-022-07321-x","type":"journal-article","created":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T22:02:17Z","timestamp":1660428137000},"page":"8611-8614","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A stitch in time saves nine: timely use of N-acetyl cysteine (NAC) for chemotherapy-induced veno-occlusive disease (VOD)\u2014is it a cost-effective alternative?"],"prefix":"10.1007","volume":"30","author":[{"given":"Harish Varma","family":"Tandra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thirumala","family":"Rupakumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3796-8782","authenticated-orcid":false,"given":"Kalasekhar","family":"Vijayasekharan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prasanth","family":"V R","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guruprasad","family":"C S","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priya Kumari","family":"T","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,13]]},"reference":[{"issue":"2","key":"7321_CR1","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/1097-0142(19880715)62:2<270::AID-CNCR2820620208>3.0.CO;2-B","volume":"62","author":"DM Green","year":"1988","unstructured":"Green DM, Finklestein JZ, Norkool P, D\u2019Angio GJ (1988) Severe hepatic toxicity after treatment with single-dose dactinomycin and vincristine. A report of the National Wilms\u2019 Tumor Study. Cancer 62(2):270\u20133","journal-title":"Cancer"},{"issue":"12","key":"7321_CR2","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1002\/(SICI)1097-0142(19970615)79:12<2435::AID-CNCR21>3.0.CO;2-R","volume":"79","author":"JA Ortega","year":"1997","unstructured":"Ortega JA, Donaldson SS, Ivy SP, Pappo A, Maurer HM (1997) Venoocclusive disease of the liver after chemotherapy with vincristine, actinomycin D, and cyclophosphamide for the treatment of rhabdomyosarcoma. A report of the Intergroup Rhabdomyosarcoma Study Group. Childrens Cancer Group, the Pediatric Oncology Group, and the Pediatric Intergroup Statistical Center. Cancer 79(12):2435\u20139","journal-title":"Cancer"},{"issue":"5","key":"7321_CR3","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2165\/11531840-000000000-00000","volume":"12","author":"MG Cefalo","year":"2010","unstructured":"Cefalo MG, Maurizi P, Arlotta A, Scalzone M, Attin\u00e0 G, Ruggiero A et al (2010) Hepatic veno-occlusive disease: a chemotherapy-related toxicity in children with malignancies. Paediatr Drugs 12(5):277\u2013284","journal-title":"Paediatr Drugs"},{"issue":"1","key":"7321_CR4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1399-3046.2006.00612.x","volume":"11","author":"SW Eber","year":"2007","unstructured":"Eber SW, Gungor T, Veldman A, Sykora K, Scherer F, Fischer D et al (2007) Favorable response of pediatric stem cell recipients to human protein C concentrate substitution for veno-occlusive disease. Pediatr Transplant 11(1):49\u201357","journal-title":"Pediatr Transplant"},{"key":"7321_CR5","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/bmt.2016.130","volume":"51","author":"M Mohty","year":"2016","unstructured":"Mohty M, Malard F, Abecassis M et al (2016) Revised diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation. Bone Marrow Transplant 51:906\u2013912. https:\/\/doi.org\/10.1038\/bmt.2016.130","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"7321_CR6","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/bmt.2017.161","volume":"53","author":"S Corbacioglu","year":"2018","unstructured":"Corbacioglu S, Carreras E, Ansari M, Balduzzi A, Cesaro S, Dalle J-H et al (2018) Diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation. Bone Marrow Transplant 53(2):138\u2013145","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"7321_CR7","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/MPH.0b013e3182a8f352","volume":"36","author":"RS Kotecha","year":"2014","unstructured":"Kotecha RS, Buckland A, Phillips MB, Cole CH, Gottardo NG (2014) Hepatic sinusoidal obstruction syndrome during chemotherapy for childhood medulloblastoma: report of a case and review of the literature. J Pediatr Hematol Oncol 36(1):76\u201380","journal-title":"J Pediatr Hematol Oncol"},{"key":"7321_CR8","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/(SICI)1096-911X(199710)29:4<245::AID-MPO2>3.0.CO;2-M","volume":"29","author":"G Bisogno","year":"1997","unstructured":"Bisogno G, de Kraker J, Weirich A et al (1997) Veno-occlusive disease of the liver in children treated for Wilms tumor. Med Pediatr Oncol 29:245\u2013251","journal-title":"Med Pediatr Oncol"},{"issue":"5","key":"7321_CR9","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/(SICI)1096-911X(199911)33:5<462::AID-MPO5>3.0.CO;2-8","volume":"33","author":"R Ludwig","year":"1999","unstructured":"Ludwig R, Weirich A, Abel U, Hofmann W, Graf N, Tournade MF (1999) Hepatotoxicity in patients treated according to the nephroblastoma trial and study SIOP-9\/GPOH. Med Pediatr Oncol 33(5):462\u2013469","journal-title":"Med Pediatr Oncol"},{"issue":"3","key":"7321_CR10","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/sj.bmt.1705899","volume":"41","author":"VT Ho","year":"2008","unstructured":"Ho VT, Revta C, Richardson PG (2008) Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies. Bone Marrow Transplant 41(3):229\u2013237","journal-title":"Bone Marrow Transplant"},{"key":"7321_CR11","first-page":"45","volume":"111","author":"L Bonanomi","year":"1980","unstructured":"Bonanomi L, Gazzaniga A (1980) Toxicological, pharmacokinetic and metabolic studies on acetylcysteine. Eur J Respir Dis Suppl 111:45\u201351","journal-title":"Eur J Respir Dis Suppl"},{"issue":"8705","key":"7321_CR12","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1016\/0140-6736(90)91388-Q","volume":"335","author":"PM Harrison","year":"1990","unstructured":"Harrison PM, Keays R, Bray GP, Alexander GJ, Williams R (1990) Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine. Lancet Lond Engl 335(8705):1572\u20131573","journal-title":"Lancet Lond Engl"},{"issue":"9","key":"7321_CR13","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/sj.bmt.1705969","volume":"41","author":"L Barkholt","year":"2008","unstructured":"Barkholt L, Remberger M, Hassan Z, Fransson K, Omazic B, Svahn B-M et al (2008) A prospective randomized study using N-acetyl-L-cysteine for early liver toxicity after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 41(9):785\u2013790","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"7321_CR14","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/sj.bmt.1702387","volume":"25","author":"O Ringd\u00e9n","year":"2000","unstructured":"Ringd\u00e9n O, Remberger M, Lehmann S, Hentschke P, Mattsson J, Klaesson S et al (2000) N-acetylcysteine for hepatic veno-occlusive disease after allogeneic stem cell transplantation. Bone Marrow Transplant 25(9):993\u2013996","journal-title":"Bone Marrow Transplant"},{"key":"7321_CR15","doi-asserted-by":"publisher","first-page":"527","DOI":"10.7150\/jca.2.527","volume":"2","author":"AC Lee","year":"2011","unstructured":"Lee AC, Goh PY (2011) Dactinomycin-induced hepatic sinusoidal obstruction syndrome responding to treatment with N-acetylcysteine. J Cancer 2:527\u2013531","journal-title":"J Cancer"},{"issue":"4","key":"7321_CR16","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1002\/pbc.23142","volume":"57","author":"RK Sahoo","year":"2011","unstructured":"Sahoo RK, Sharma A (2011) Sinusoidal obstruction syndrome during induction therapy for acute lymphoblastic leukemia managed with N-acetyl cysteine. Pediatr Blood Cancer 57(4):700","journal-title":"Pediatr Blood Cancer"},{"key":"7321_CR17","doi-asserted-by":"crossref","unstructured":"Lee AC-W, Aung L. Treatment of hepatic veno-occlusive disease in children with N-acetylcysteine. Pediatr Blood Cancer. 2019;66(2):e27518.","DOI":"10.1002\/pbc.27518"},{"key":"7321_CR18","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/bcp.12789","volume":"81","author":"AL Chiew","year":"2016","unstructured":"Chiew AL, Isbister GK, Duffull SB, Buckley NA (2016) Evidence for the changing regimens of acetylcysteine. Br J Clin Pharmacol 81:471\u2013481","journal-title":"Br J Clin Pharmacol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-022-07321-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-022-07321-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-022-07321-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T10:34:55Z","timestamp":1667471695000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-022-07321-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,13]]},"references-count":18,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["7321"],"URL":"https:\/\/doi.org\/10.1007\/s00520-022-07321-x","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"type":"print","value":"0941-4355"},{"type":"electronic","value":"1433-7339"}],"subject":[],"published":{"date-parts":[[2022,8,13]]},"assertion":[{"value":"9 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}